Veligrotug

• Target:

  IGF-1R

• Related Pathways:

  Tyrosine Kinase/Adaptors

• Purity:

  0.998

• Bioactivity:

  Veligrotug is an intravenously administered anti-insulin-like growth factor-1 receptor antibody developed for the treatment of thyroid eye disease (TED) . Veligrotug has demonstrated rapid reductions in diplopia as well as improvements in orbital inflammation, thereby highlighting its potential as a targeted biologic research tool in autoimmune ophthalmopathy.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  2728655-31-8